RE:One more thing ......,,,,,I wonder just what Midatech gains overall in this so called merger,,,,,buy out,,or what ever dogs breakfast you can call it?,,,,seems they are not the designer of all,,,it looks like the reverse splitting has them in similar market cap decay these past years,,,,,looks more like a round about corporate raid taking place under a different name!
I do think Midatech is a much more aggresive company than the slackness we have all observed within BTI,,,,and it is more advanced in its timelime with its pipeline. That bodes a tad better for us. The % of final ownership by BTI shareholders in the new company Biodexa is an issue imo,,,,that point maybe the biggest hurdle on this morphosis!,,,what % of market cap potential is in xB3 and the EGF vs the Midatech technology??..seems we dont match up,,in fact we seem to be taking less potential to the party than what Midatech is expected to deliver.
A lot of ifs and known unknowns around this deal as is said. There also seems to be fingers in this pie which have an orchestrated advantage over both of the main parties involved. Havent we all noticed!